GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Alpha Teknova Inc.
Alpha Teknova produces reagents for the biopharmaceutical industry. Its share price depends on the amount of R&D funding and the pace of production of cell and gene therapies, which require high-quality materials.
Share prices of companies in the market segment - Medical instruments
Alpha Teknova produces reagents and components necessary for the development and production of vaccines, gene therapies, and other biopharmaceutical products. We've categorized it as "Medical Instruments." The chart below shows the dynamics of the life sciences supplier sector.
Broad Market Index - GURU.Markets
Alpha Teknova produces reagents and components necessary for the development and production of vaccines, gene therapies, and other biopharmaceutical products. We've categorized it as "Medical Instruments." The chart below shows the dynamics of the life sciences supplier sector.
Change in the price of a company, segment, and market as a whole per day
TKNO - Daily change in the company's share price Alpha Teknova Inc.
Daily fluctuations in Alpha Teknova, a supplier of biopharma reagents, reflect the state of the industry. change_co measures sensitivity to R&D and drug production costs. This metric, while unspectacular, is important for analyzing biotech service companies on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medical instruments
Alpha Teknova, Inc. is a supplier of reagents to the biotechnology industry. This chart shows the average daily volatility of the sector. Comparison with the dynamics of TKNO, a key supplier, helps assess its stability.
Daily change in the price of a broad market stock, index - GURU.Markets
Teknova is a manufacturer of reagents for biomedical research and production. Its business serves as a barometer of global scientific activity. The chart below shows general market fluctuations, which can be used to assess Teknova's stability.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Alpha Teknova Inc.
Alpha Teknova, Inc.'s year-over-year performance tells the story of a company supplying critical reagents to the biopharmaceutical industry. Its 12-month market cap growth reflects demand for its products, which are used to produce cell and gene therapies. It is an infrastructure player benefiting from the overall growth of the sector.
Annual dynamics of market capitalization of the market segment - Medical instruments
Alpha Teknova, Inc. produces critical reagents for the biotech and pharmaceutical industries. Its products are "consumables" for R&D. The chart shows how its business, dependent on biotech funding, and its path to profitability impact its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Teknova, a supplier of biotech reagents, is a gold mine for the sector. Demand for its products is stable, as drug development continues. The company's stock performance demonstrates the resilience typical of companies providing scientific infrastructure, making it less cyclical.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Alpha Teknova Inc.
Alpha Teknova's performance as a supplier of reagents for biopharma will depend on R&D cycles. Monthly fluctuations on the chart will reflect demand for its products from biotech companies, which is linked to funding levels in the industry and activity in the development of cell and gene therapies.
Monthly dynamics of market capitalization of the market segment - Medical instruments
Alpha Teknova produces critical reagents, such as culture media, for the production of gene therapies, vaccines, and other biopharmaceuticals. It is a key player in the biotech revolution. The chart below shows the overall dynamics of the medical instruments and consumables sector.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Alpha Teknova, Inc. produces reagents for the biopharmaceutical industry. Demand for its products depends on activity in drug development and manufacturing. The company's shares reflect the health of the biotech sector and can move in sync with its rhythm, which doesn't always align with the broader market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Alpha Teknova Inc.
Shares of Alpha Teknova, a supplier of reagents for the biopharmaceutical industry, reflect activity in the sector. Weekly price movements depend on the funding levels of biotech companies and the pace of their research and production. The chart below shows how short-term trends in the biotech world influence the valuation of this key supplier.
Weekly dynamics of market capitalization of the market segment - Medical instruments
Is Alpha Teknova keeping pace with the biotech sector? The chart below compares the reagent supplier's weekly stock performance with the industry average. This helps assess whether its business is less volatile than that of drug developers, reflecting more stable demand for research consumables.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Alpha Teknova produces reagents for the biopharmaceutical industry. Its business is the "shovels and picks" of the biotech industry. This chart compares its weekly performance to the market to assess how its results are influenced by the overall level of funding and activity in the biotech industry.
Market capitalization of the company, segment and market as a whole
TKNO - Market capitalization of the company Alpha Teknova Inc.
The Alpha Teknova, Inc. stock price chart reflects its role as a supplier of critical reagents for the biopharmaceutical industry. The company's market capitalization depends on the volume of drug and vaccine production by its customers. The price chart shows how investors value this "shovel supplier" during the biotech gold rush.
TKNO - Share of the company's market capitalization Alpha Teknova Inc. within the market segment - Medical instruments
Alpha Teknova, Inc. captures its market share by producing critical reagents for the biopharmaceutical industry. Its market capitalization reflects its role as a supplier of key ingredients for cell and gene therapies.
Market capitalization of the market segment - Medical instruments
This graph shows the total value of suppliers of critical reagents for the biopharmaceutical industry. Alpha Teknova is one such manufacturer. The dynamics in the chart reflect the growth of the entire cell and gene therapy industry, which is the company's primary consumer.
Market capitalization of all companies included in a broad market index - GURU.Markets
Here's the market valuation of a supplier of biotech building blocks. Alpha Teknova's market capitalization reflects the demand for its reagents for drug production and gene therapy. The chart shows the company's importance as a supplier of critical consumables to the global pharmaceutical industry.
Book value capitalization of the company, segment and market as a whole
TKNO - Book value capitalization of the company Alpha Teknova Inc.
The graph below shows the value of Alpha Teknova's inventory. The line represents its production capacity for biopharmaceutical reagents. Its growth is directly related to investments in expanding production to meet the needs of clients developing cell and gene therapies.
TKNO - Share of the company's book capitalization Alpha Teknova Inc. within the market segment - Medical instruments
Alpha Teknova's core asset is its state-of-the-art manufacturing facility, which produces reagents needed for the biopharmaceutical industry. The chart shows the company's share of this critical infrastructure for the R&D and drug manufacturing supply chain.
Market segment balance sheet capitalization - Medical instruments
Below you can see the overall book value of the biotech sector. Against this backdrop, Alpha Teknova, as a producer of biopharma reagents, is a capital-intensive service player. Its business requires the ownership of clean production facilities to ensure the quality and sterility of its products.
Book value of all companies included in the broad market index - GURU.Markets
Alpha Teknova produces reagents and components for the biopharmaceutical industry. The company's assets are sterile production facilities. Their balance sheet represents the value of the "kitchen" where critical "ingredients" are prepared for the creation of new world-changing drugs and vaccines.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Alpha Teknova Inc.
Alpha Teknova's balance sheet is the value of its production capacity. Market valuation, when it's below book value, reflects the decline in demand for its reagents since the end of the COVID-19 pandemic. The MvsBCap_Co < 1 chart tells the story of how a company that thrived on the boom faced its end.
Market to book capitalization ratio in a market segment - Medical instruments
Alpha Teknova produces critical reagents for the biopharmaceutical industry. The chart shows how the market assesses its role in the supply chain for drugs, vaccines, and gene therapies. This assessment reflects its manufacturing capacity and quality control.
Market to book capitalization ratio for the market as a whole
Alpha Teknova supplies critical reagents, such as cell media, to the biotech and pharmaceutical industries. The company is a vital link in the supply chain for drug development and manufacturing. This chart helps assess how the market perceives pharmaceutical suppliers compared to overall market dynamics.
Debts of the company, segment and market as a whole
TKNO - Company debts Alpha Teknova Inc.
For Alpha Teknova, a supplier of critical reagents for the biopharmaceutical industry, debt policy is aimed at expanding production. This chart shows how the company is investing in building new capacity to meet growing demand from cell and gene therapy developers. Debt here represents an investment in biotech infrastructure.
Market segment debts - Medical instruments
Alpha Teknova supplies critical reagents to the biopharmaceutical industry, used in drug development and manufacturing. Quality and reliability of supply are crucial. This chart shows how the company is funding its production capacity to meet growing demand from biotech companies.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Alpha Teknova Inc.
Alpha Teknova supplies reagents to the biotech and pharmaceutical industries. This chart shows its capital structure. For a supplier of critical consumables, a strong balance sheet is important for customer confidence. Debt levels may reflect investments in production capacity to meet growing demand.
Market segment debt to market segment book capitalization - Medical instruments
Alpha Teknova produces critical reagents for the biopharmaceutical industry. Demand for its products is growing alongside the development of cell and gene therapy. The chart shows how the company's debt strategy for production expansion compares to the overall market capitalization of the entire life sciences sector.
Debt to book value of all companies in the market
Alpha Teknova (TKNO) produces reagents for the biopharmaceutical industry, essential for drug development and manufacturing. It serves a growing market. This chart shows the dynamics of the debt-to-equity ratio across the entire market, helping to understand how the biotech company manages its growth and financing.
P/E of the company, segment and market as a whole
P/E - Alpha Teknova Inc.
This chart for Alpha Teknova, a producer of critical reagents for the biopharmaceutical industry, shows a valuation equivalent to a "shovel maker during a gold rush." The P/E is dependent on the overall health and production volumes of its gene therapy and vaccine manufacturing sectors, which are its key customers.
P/E of the market segment - Medical instruments
This chart shows the average P/E valuation for biopharma consumables suppliers. For Alpha Teknova, this is an important barometer. Comparing its P/E to the industry average helps understand how investors view its role as a "shovel supplier" for the rapidly growing gene therapy and biopharmaceutical manufacturing sectors.
P/E of the market as a whole
Alpha Teknova produces reagents and components necessary for the production of biopharmaceuticals, gene therapies, and vaccines. The company is a critical supplier to the biotech and pharmaceutical industries. This chart, reflecting overall sentiment, helps understand how investors value biotech infrastructure companies.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Alpha Teknova Inc.
Alpha Teknova supplies critical reagents, such as cell media and buffers, to the pharmaceutical and biotechnology industries. This chart shows expectations for stable growth in the life sciences sector. This valuation is driven by demand for its products from developers of gene therapies, vaccines, and other biologics, which generates recurring revenue.
%20P%2FE%20Alpha%20Teknova%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Alpha-Teknova-Inc.&v=1772622623175 "Chart of the company's future (projected) P/E Alpha Teknova Inc.")
Future (projected) P/E of the market segment - Medical instruments
Alpha Teknova supplies critical reagents to the biopharmaceutical industry, used in the production of drugs and vaccines. This chart compares the company's future profitability expectations with the sector average. It reflects the market's confidence in its ability to grow alongside the gene therapy and cellular medicine market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medical-instruments&v=1772622623225 "Future (projected) P/E graph of the market segment - Medical instruments")
Future (projected) P/E of the market as a whole
Alpha Teknova produces reagents for the biotech and pharmaceutical industries. Its products serve as consumables for drug research and production. This market expectations chart is an indicator of activity in Teknova's sector. Growing optimism means increased R&D budgets and, consequently, increased demand for its products.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772622623365 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Alpha Teknova Inc.
Alpha Teknova produces reagents and components necessary for the production of biopharmaceuticals, gene therapies, and vaccines. The company is a key supplier to the biotechnology industry, relying on growth and activity in the life sciences sector for its profits.
Profit of companies in the market segment - Medical instruments
Alpha Teknova produces reagents and components necessary for the development and production of biopharmaceuticals. The company is a key supplier to the R&D sector. This chart illustrates how biotech service companies form a stable foundation for the entire industry, with profitability less dependent on the success of individual clinical trials.
Overall market profit
Alpha Teknova produces reagents for the biopharmaceutical industry, essential for drug development and production. The company is a "pick and chip" supplier during the biotech gold rush. Demand for its products depends on the volume of R&D in the industry, which can be more stable than the overall economy.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Alpha Teknova Inc.
Alpha Teknova produces critical reagents used in the development and production of biopharmaceuticals. This chart shows profit expectations, which depend on the health of the biotech and pharmaceutical industries. Increased investment in gene therapy and vaccine development directly increases demand for the company's products.
%20profit%20of%20the%20company%20Alpha%20Teknova%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Alpha-Teknova-Inc.&v=1772622623506 "Graph of future (projected) profit of the company Alpha Teknova Inc.")
Future (predicted) profit of companies in the market segment - Medical instruments
Alpha Teknova produces critical reagents for the biopharmaceutical industry, used in the production of drugs and vaccines. This chart shows the profit forecast for the medical instruments and consumables sector. It reflects expectations for growth in biopharmaceutical production, a trend that is the main driver of demand for Teknova products.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medical-instruments&v=1772622623513 "Graph of future (predicted) profits of companies in a market segment - Medical instruments")
Future (predicted) profit of the market as a whole
Alpha Teknova produces reagents necessary for the production of biopharmaceuticals. Demand for its products is directly dependent on activity in the biotech and pharmaceutical industries. This trend, reflecting overall sentiment, influences investment in the development and production of new drugs, which drives Teknova.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772622623536 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Alpha Teknova Inc.
Alpha Teknova produces critical reagents used in the development and production of biopharmaceuticals, including cell and gene therapies. This chart shows how investors value its revenue, which is growing alongside the rapid development of the biotech industry, representing a "shovel in the gold rush" for the sector.
P/S market segment - Medical instruments
Alpha Teknova produces and markets critical reagents required for the production of biopharmaceuticals, such as cell and gene therapies. The company delivers high quality and customization to its customers. This chart shows the average rating in the sector, helping to understand how the market values Teknova's role in the biopharma supply chain.
P/S of the market as a whole
Alpha Teknova supplies critical reagents, such as cell media, to the biopharmaceutical industry at all stages, from research to commercial drug production. It's the "shovel and pickaxe" of biotech. This total market valuation chart allows you to compare how investors value the revenue of a company serving the growing pharmaceutical industry.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Alpha Teknova Inc.
Alpha Teknova supplies reagents to the biopharmaceutical industry. Future revenue depends on the production volumes of drugs and vaccines by its customers. This chart shows how investors view the growth of the biopharmaceutical market and the company's role as a key supplier in this ecosystem.
%20P%2FS%20Alpha%20Teknova%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Alpha-Teknova-Inc.&v=1772622623649 "The graph of the company's future (projected) P/S Alpha Teknova Inc.")
Future (projected) P/S of the market segment - Medical instruments
Alpha Teknova produces critical reagents, such as cell culture media, for the biopharmaceutical industry. This chart compares the company's estimated future sales with those of other medical instrument manufacturers. It shows how investors view demand for its products, which is growing alongside the gene therapy and biomanufacturing industries.
%20P%2FS%20market%20segment%20graph%20-%20Medical%20instruments&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medical-instruments&v=1772622623716 "Future (projected) P/S market segment graph - Medical instruments")
Future (projected) P/S of the market as a whole
Alpha Teknova produces reagents necessary for biotech and pharmaceutical research. The company is a supplier of "consumables" for science. Market optimism, as seen in this chart, indicates that investors believe in biotech innovation. This leads to increased R&D funding, which directly increases demand for Teknova's products.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772622623877 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Alpha Teknova Inc.
Alpha Teknova supplies critical reagents, such as culture media and buffers, to the pharmaceutical and biotechnology industries. The company's revenue comes from sales of these consumables, which are essential for drug production and research. The graph shows demand, which is growing in line with activity in the life sciences sector.
Sales of companies in the market segment - Medical instruments
Alpha Teknova supplies critical reagents to the biopharmaceutical industry. The company custom-manufactures culture media and buffer solutions essential for the production of cell and gene therapies, vaccines, and other biologics. This graph illustrates the growth of the biopharmaceutical industry, where Teknova is a vital link in the supply chain, ensuring quality and reliability.
Overall market sales
Alpha Teknova produces reagents necessary for the development and production of biopharmaceuticals. Demand for its products is directly dependent on activity in the biotech and pharmaceutical industries. This dynamic, reflecting the overall economic situation, influences R&D investment, which translates into orders for Teknova.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Alpha Teknova Inc.
Alpha Teknova supplies critical reagents, such as culture media and buffers, to the pharmaceutical and biotechnology industries. These materials are essential for drug production and research. This chart shows analysts' expectations for biopharmaceutical market growth, which directly impacts demand for Teknova products.
%20sales%20of%20the%20company%20Alpha%20Teknova%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Alpha-Teknova-Inc.&v=1772622624046 "Schedule of future (projected) sales of the company Alpha Teknova Inc.")
Future (projected) sales of companies in the market segment - Medical instruments
Alpha Teknova supplies reagents and components to the biotech, pharmaceutical, and research industries. This chart shows the forecast for the medical instruments sector. It allows one to assess how the growth of the life sciences industry and the need for high-quality consumables for drug development and diagnostics are driving demand for the company's products.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medical-instruments&v=1772622624079 "Schedule of future (projected) sales of companies in the market segment - Medical instruments")
Future (projected) sales of the market as a whole
Alpha Teknova, Inc. produces reagents for use in the biotech and pharmaceutical industries. This chart, reflecting activity in the life sciences sector, is a direct indicator for the company. Growth in research, development, and production of biopharmaceuticals directly increases demand for the high-quality reagents Teknova supplies.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772622624121 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Alpha Teknova Inc.
Alpha Teknova produces critical reagents used in the development and production of biopharmaceuticals, vaccines, and gene therapies. It provides the building blocks for the biotech industry. This chart shows how effectively the company is meeting demand from the rapidly growing life sciences sector.
Market segment marginality - Medical instruments
Alpha Teknova produces critical reagents used in the development and production of biopharmaceuticals. They are a vital link in the biotech supply chain. This chart illustrates the profitability of their model, which relies on ensuring high quality and reliable supply for the rapidly growing cell and gene therapy market.
Market marginality as a whole
Alpha Teknova provides critical reagents for the biotech and pharmaceutical industries. While overall economic profitability fluctuates, their business is stable. They are the "shovels and picks" in the biotech gold rush. Their profitability depends on the overall growth of R&D in the industry, not on the success of any one company.
Employees in the company, segment and market as a whole
Number of employees in the company Alpha Teknova Inc.
Alpha Teknova is a manufacturer of high-quality reagents for the biopharmaceutical industry. This graph shows the team supporting a critical step in drug production. The growth of the team is directly related to the growth of the biotech industry and the demand for customized reagents for cell and gene therapy.
Share of the company's employees Alpha Teknova Inc. within the market segment - Medical instruments
Alpha Teknova supplies critical reagents to the biopharmaceutical industry, essential for the production of cell and gene therapies. This chart shows its market share, reflecting its role as a key supplier to this rapidly growing sector and the team that ensures the highest quality products for the development of the medicines of the future.
Number of employees in the market segment - Medical instruments
Alpha Teknova supplies critical reagents to the biopharmaceutical industry, such as cell culture media. This chart shows employment growth in the life sciences sector. The increase reflects the rapid growth of biopharma and drug developers' need for high-quality, reliable consumables for their research and production.
Number of employees in the market as a whole
Alpha Teknova, Inc. produces critical reagents such as culture media and buffers used in the production of biopharmaceuticals, gene therapies, and vaccines. This graph reflects overall employment, and companies like Teknova are unsung but essential suppliers to the entire biotech industry, enabling its growth and job creation.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Alpha Teknova Inc. (TKNO)
Alpha Teknova, Inc. produces reagents for the biotech and pharmaceutical industries. It's a support business that nonetheless requires precision and quality. This chart shows a moderate capitalization per employee, reflecting the balance between manufacturing processes and scientific expertise. Manufacturing efficiency plays a key role here.
%20of%20the%20company%20Alpha%20Teknova%20Inc.%20(TKNO)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Alpha-Teknova-Inc.-TKNO&v=1772622624576 "Chart of market capitalization per employee (in thousands of dollars) of the company Alpha Teknova Inc. (TKNO)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
DouYu International is one of China's leading video game streaming platforms, similar to Twitch. For an internet company with a huge audience, this metric reflects monetization efficiency. The chart demonstrates how successfully DouYu generates market value through its team, a key indicator for content-based platforms.
%20by%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medical-instruments&v=1772622624623 "Market capitalization per employee (in thousands of dollars) by market segment - Medical instruments")
Market capitalization per employee (in thousands of dollars) for the overall market
Alpha Teknova produces critical reagents used in the production of biopharmaceuticals, such as cell and gene therapies. It is the "pixes and shovels" supplier of the biotech revolution. This chart reflects how the market assesses the importance of their products to the overall industry.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772622624700 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Alpha Teknova Inc. (TKNO)
Alpha Teknova (TKNO) produces critical reagents (fluids, "buffers") for the biopharmaceutical industry and gene therapy. These are "consumables" for science. This graph shows the efficiency of their manufacturing and laboratory division. It measures how much profit each employee generates by producing these highly purified reagents.
%20Chart%20Alpha%20Teknova%20Inc.%20(TKNO)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Alpha-Teknova-Inc.-TKNO&v=1772622624709 "Company Profit Per Employee (in thousands of dollars) Chart Alpha Teknova Inc. (TKNO)")
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
Alpha Teknova supplies critical reagents to the biotech industry. They produce consumables for drug and gene therapy production. Their business is the "shovel" of biotech. This chart shows an industry benchmark. It helps evaluate how efficiently Teknova utilizes its production personnel.
%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medical-instruments&v=1772622624713 "Chart of profit per employee (in thousands of dollars) in the market segment - Medical instruments")
Profit per employee (in thousands of dollars) for the market as a whole
Alpha Teknova manufactures and supplies critical laboratory reagents (such as culture media) to biotech and pharmaceutical companies. They are the "picks and shovels" of the R&D industry. This chart demonstrates how effectively their manufacturing and sales teams can serve the rapidly growing biotech sector with essential consumables.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772622624720 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Alpha Teknova Inc. (TKNO)
Alpha Teknova produces reagents for the biopharmaceutical industry, essential for the production of drugs and vaccines. This chart shows performance in the B2B healthcare segment. The increase in revenue per employee reflects increased demand for their products from large pharmaceutical companies expanding their production.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Alpha-Teknova-Inc.-TKNO&v=1772622624752 "Sales chart per company employee Alpha Teknova Inc. (TKNO)")
Sales per employee in the market segment - Medical instruments
Alpha Teknova (TKNO) is a company that manufactures and sells critical reagents (media, buffers) for the biotech and pharmaceutical industries. This chart shows how much revenue each employee generates from the sale of their consumables. This is an indicator of their operational efficiency in the "life science tools" sector.
Sales per employee for the market as a whole
Alpha Teknova (TKNO) is a B2B company that produces critical reagents (buffers, media) for the biotech industry. They also manufacture consumables for R&D and drug production. This chart shows how efficiently their manufacturing staff generates revenue by producing and selling these essential, but often low-margin, laboratory supplies.
Short shares by company, segment and market as a whole
Shares shorted by company Alpha Teknova Inc. (TKNO)
Alpha Teknova is a company that supplies reagents (such as culture media) to the biotech and pharmaceutical industries. This chart shows bearish bets. The shorts could be driven by a slowdown in the biotech sector. As biotechs cut R&D spending, they order fewer reagents, which hurts suppliers like Teknova.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Alpha-Teknova-Inc.-TKNO&v=1772622625001 "Short Shares Chart for the Company Alpha Teknova Inc. (TKNO)")
Shares shorted by market segment - Medical instruments
Alpha Teknova (TKNO) is a company that produces critical reagents (media, buffers) for the biopharmaceutical industry used in R&D and drug production. This chart shows bets against the life sciences sector. The rising bets against the industry reflect concerns that biotech companies will cut R&D budgets, which will directly reduce demand for Teknova consumables.
Shares shorted by the overall market
Alpha Teknova (TKNO) produces critical reagents for the biotech and pharmaceutical industries. It is a B2B company serving R&D. When this chart shows rising fear, investors fear that biotech companies (TKNO's clients) will cut their research budgets due to funding issues.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Alpha Teknova Inc. (TKNO)
Alpha Teknova supplies reagents to the biopharmaceutical industry. The business is a consumable for R&D. This chart above 70 may reflect a boom in biotech. Oversold levels (<30) are often associated with a "venture winter," concerns about client R&D budget cuts, or quality/supply issues.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Alpha-Teknova-Inc.-TKNO&v=1772622625221 "RSI 14 indicator chart for the company's stock Alpha Teknova Inc. (TKNO)")
RSI 14 Market Segment - Medical instruments
Alpha Teknova is a "picks and shovels" supplier for biotech. The company produces critical reagents and media needed for the production of drugs, vaccines, and cell therapies. This chart measures the collective momentum of the biotech equipment and reagents sector. It shows whether TKNO is moving with the overall biotech sector or with its own unique products.
RSI 14 for the overall market
Alpha Teknova (TKNO) produces laboratory consumables (reagents). This chart shows that its business is "defensive." Unlike expensive equipment, biotech companies need these consumables in both euphoria and panic to continue basic research. In panic, investors value this stable, recurring income.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast TKNO (Alpha Teknova Inc.)
Alpha Teknova produces critical reagents (media, buffers) for the biotech and pharmaceutical industries. This chart shows the average analyst forecast. Their targets are based on demand for these consumables from R&D labs and cell and gene therapy manufacturers.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-TKNO-Alpha-Teknova-Inc.&v=1772622625470 "A chart showing analyst consensus forecasts for the expected stock price. TKNO (Alpha Teknova Inc.)")
The difference between the consensus estimate and the actual stock price TKNO (Alpha Teknova Inc.)
Teknova (TKNO) is a biotech supplier. They custom-produce critical reagents (buffers, media) for R&D in gene therapy and diagnostics. This chart shows their niche assessment. It measures the gap between the price and the consensus target, reflecting the potential analysts see in their scientific consumables business.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-TKNO-Alpha-Teknova-Inc.&v=1772622625551 "A chart showing the difference between the consensus forecast and the actual stock price. TKNO (Alpha Teknova Inc.)")
Analyst consensus forecast for stock prices by market segment - Medical instruments
Alpha Teknova (TKNO) is a biotech supplier. The company custom-manufactures critical reagents (fluids, buffers) needed for R&D and drug production. This chart shows general expectations for the medical instruments sector. It reflects whether experts believe outsourcing will grow in big pharma.
Analysts' consensus forecast for the overall market share price
Alpha Teknova produces laboratory-grade reagents (media, buffers), which are critical consumables for biotech and pharmaceutical research. This chart shows the overall market sentiment. For Teknova, whose business is the "shovel" for the biotech gold rush, the overall optimism is important, as it reflects the high level of R&D activity in the sector.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Alpha Teknova Inc.
Alpha Teknova (TKNO) is a biotech kitchen. They don't make drugs, but rather custom-produce critical reagents (buffers, cell growth media) that pharmaceutical companies use in their R&D and manufacturing. This chart is a summary indicator of their service model. It reflects their ability to retain clients and their dependence on biotech R&D budgets.
AKIMA Market Segment Index - Medical instruments
Alpha Teknova supplies reagents (such as culture media) to biotech and pharmaceutical companies, serving as a shovel-maker in the biotech gold rush. This chart shows the average index for the medical instruments sector. It helps investors understand how effective Teknova's business model is compared to the industry average.
The AKIM Index for the overall market
Alpha Teknova is a manufacturer of critical reagents for bioprocessing, cell, and gene therapy. It delivers speed for scientists. This chart, reflecting the market average, is just a backdrop. It helps assess how TKNO, a supplier of consumables for innovation, compares to the overall macroeconomic fluctuations in biotech.
